Pharma Marketing Network

DECEMBER 17, 2021

The wave of interest in sustainability follows the value chain from top-tier pharmaceutical companies to their suppliers of every size. About 80% of pharmaceutical companies have announced a commitment to becoming carbon-neutral or made a net-zero pledge for carbon emissions. Where do most organizations start?

Pharmaceutical Companies 103

Pharmaceutical Companies Pharmaceutical Companies Communication 103

Pharmaceutical Technology

JULY 14, 2022

Prior to this development, Innoviva signed a definitive merger agreement to acquire all of the outstanding shares of La Jolla Pharmaceutical Company for an enterprise value of nearly $149m, through its wholly owned subsidiary.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies 59

Pharma Marketing Network

MAY 4, 2025

As 2025 unfolds, the stakes for pharmaceutical companies continue to rise. While these methods remain valuable, the definition of research has expanded. In todays complex landscape, pharma market research isnt just about collecting dataits about transforming that data into actionable intelligence.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Express Pharma

OCTOBER 4, 2024

Pressure on margins: A reality check for India Pharma In recent years, Indian pharmaceutical companies have seen a substantial decline in profitability, dropping by approximately 20-30 per cent over the past six to eight years, aside from a brief surge during the pandemic.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies 105

Pharmaceutical Technology

JANUARY 9, 2023

Italian pharmaceutical company Chiesi Farmaceutici has signed a definitive agreement to acquire Amryt Pharma in a total deal valued at up to $1.48bn. The Boards of Directors of both companies have unanimously approved the transaction. Under the deal, Amryt shareholders will receive $14.50

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

OCTOBER 14, 2022

US-based pharmaceutical companies Enliven Therapeutics and Imara have entered a definitive merger deal in an all-stock transaction to advance oncology product candidates. Once the merger has closed, a clinical-stage biopharmaceutical company will be created that will operate under the name Enliven Therapeutics.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

European Pharmaceutical Review

JULY 4, 2024

It begs the question of why only two botanical drug products have obtained FDA approval and fulfilled the Botanical Guidance definition of a botanical product. Prior to joining Fieldfisher, Taly spent four years working as in-house counsel for a leading tech company helping launch products across multiple EU markets.

Drug Development 103

Drug Development Documentation Biosimilars Labelling 103

European Pharmaceutical Review

SEPTEMBER 26, 2023

Pharmaceutical companies regularly transfer databases as they shift to new systems or change service providers in pursuit of higher quality and increased efficiency. However, due to configuration differences between databases (such as code list definitions), cases may not always be an exact replica of the original case.

Documentation 105

Documentation Data Entry Pharmaceutical Companies Pharmaceutical Companies 105

PharmaKinnex

MAY 20, 2022

How to Get Started with Contract Pharmaceutical Inside Sales Companies May 20, 2022. The goal of pharmaceutical companies’ sales efforts is to effectively cover their target markets to maximize sales. Consider the following three tips for working with a contract pharmaceutical inside sales company.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

OCTOBER 21, 2022

The need for therapies that can help to prolong treatment intervals for patients with wAMD is an area that pharmaceutical companies continue to focus on for this indication. The latter set of therapies need to be administered on a more-frequent basis, most of them every eight weeks on average, leading to a significant treatment burden.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies 59

Eye on FDA

SEPTEMBER 28, 2022

FDA published notice recently that the Office of Prescription Drug Promotion (OPDP) was proposing some new research related to the promotion of medicines by pharmaceutical companies. The research was new (kind of) but the direction was more of the same old focus – direct-to-consumer advertising (DTC).

Communication 69

Communication Pharmaceutical Companies Pharmaceutical Companies 69

pharmaphorum

OCTOBER 16, 2020

Now, as part of lifecycle management, pharmaceutical companies are looking more closely at drugs they have on their shelves. By definition, however, trial master files represent a much richer and more detailed source of data on a drug and how it performs.

Drug Development 105

Drug Development Immunity Immunization Pharmaceutical Companies 105

Pharmaceutical Technology

JULY 14, 2022

Despite this high number, orphan diseases are rare by definition, affecting around one in 2,000 people as defined by the European Union. Historically, the pharmaceutical industry has failed to meet the needs of this patient population. But where does this leave patients outside of these preferred markets?

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies Hospitals 59

pharmaphorum

APRIL 28, 2022

For pharmaceutical companies, rare diseases present many challenges. Because when you’re a small pharma, you are betting everything on, by definition, limited resources and you’re betting everything on one drug or one mode of action, which means that if it’s fine, it’s great.

Immunity 59

Immunity Immunization Pharmaceutical Companies Pharmaceutical Companies 59

European Pharmaceutical Review

MARCH 14, 2023

A contrary judgment would definitely interfere too widely into trademarks’ proprietors rights, who should have the right to decide which of their products are to bear which of their trademarks. He has been advising pharmaceutical companies and healthcare providers for a number of years.

Packaging 98

Packaging Generic Medicine Labelling Pharmaceutical Companies 98

Viseven

NOVEMBER 17, 2022

A medical affair is a pharmaceutical or medical company department that communicates the correct information about the drug or medical device to doctors, other medical practitioners and healthcare providers. Medical affairs definition uses clinical and scientific information to communicate the efficiency of a drug.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies Documentation 52

PharmaState Academy

DECEMBER 24, 2024

His groundbreaking work, including the book Pharmaceutical Marketing 4.0, Abstract: Post COVID-19 pandemic, pharmaceutical companies have been forced to shift their focus on digital marketing and targeting their customers in a more personalized manner. Moreover, omni-channel marketing facilitates data-driven insights.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies 52

Viseven

AUGUST 29, 2024

Pharmaceutical companies Pharmaceutical companies can transform their approaches to clinical trials with the help of 5G networks. 5G technology bridges the gap by connecting these patients with pharmacists or caregivers through high-definition video.

Communication 52

Communication Hospitals Pharmaceutical Companies Pharmaceutical Companies 52

European Pharmaceutical Review

DECEMBER 21, 2022

All traditional small molecule pharmaceuticals include carbon building blocks” Organic compounds are arguably the foundation of the pharmaceutical industry. 10 Diagnostics and biologics also heavily utilise carbon-based materials as constituting building blocks, processing aids, single-use reactors, or packaging materials.

Compounding 97

Compounding Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 97

European Pharmaceutical Review

JANUARY 27, 2025

The emergence of huge pharmaceutical companies with discrete centres of excellence in geographically dispersed locations has upended the classic model of one-stop shopping for all development functions. Success requires close attention to the principles of tech transfer to ensure the smoothest path to market.

Communication 52

Communication Documentation Pharmaceutical Companies Pharmaceutical Companies 52

European Pharmaceutical Review

JANUARY 13, 2025

If we want to lead the way in green innovation and show that the UK is open for business, we need a broader definition and recognition of innovation. We see how incentivisation has accelerated change in other sectors, such as energy, via renewable power subsidies. This is at odds with Government and NHS Net Zero ambitions and policies.

Packaging 52

Packaging Community Pharmacies Documentation Pharmaceutical Companies 52

Viseven

JULY 5, 2024

Even though the technology is capable of many things, it definitely cannot prevent its users from making bad decisions and huge mistakes. Right now, numerous pharmaceutical companies are investing in AI tools that don’t align with their goals, and they do that without even realizing the problem behind this investment.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Viseven

JANUARY 4, 2023

From life-saving drugs discovery, development, and production to clinical trials, communication, and drug target identification — AI pharmaceutical is a definite game-changer. AI algorithms and machine learning models have a significant impact on the biotech industry.

Drug Development 52

Drug Development Medical Records Communication Pharmaceutical Companies 52

GMPSOP

JUNE 28, 2024

1 – No chance of occurrence 2 – Chance of occurrence is remote 3 – Occurrence is unlikely 4 – Occurrence is probable 5 – Occurrence is definite Overall risk score: Severity X Probability The tool can also be used for analysing a manufacturing process to identify high risk steps / critical parameters. Additional documents included each month.

Documentation 59

Documentation Packaging Labelling Pharmaceutical Manufacturing 59

Viseven

APRIL 11, 2023

We will also discuss unique specifics and critical considerations for developing a content map for pharmaceutical products. Content mapping definition is the process of planning, organizing, and delivering content that aligns with the target audience’s needs at every stage of their journey. What is Content Mapping?

Customer Service 40

Customer Service Pharmaceutical Companies Pharmaceutical Companies Dosage 40

GMPSOP

MARCH 25, 2024

Validation lifecycle phases and deliverables Phase 1: Definition – Develop User Requirement Specification (URS). User requirement specification (URS) The user requirement specification (URS) should be done at the definition phase. Phase 2: Planning – Update Site Validation Master Plan. – Validation project Plan.

Documentation 59

Documentation Packaging Communication Pharmaceutical Companies 59

The Nontraditional Pharmacist

OCTOBER 14, 2019

00:05:44] I really have to say that outside of classroom experience is definitely missing. But I definitely do think that soft skills are lacking in your traditional pharmacy education. Question 4 [00:05:38] Well that being said, what is missing from the traditional pharmacy education? [00:05:44]

Communication 52

Communication Community Pharmacies Pharmaceutical Companies Pharmaceutical Companies 52

Pharma Marketing Network

APRIL 30, 2021

In a separate panel, Jenn Horonjeff, PhD, who is founder and CEO of Savvy Cooperative, stressed the importance of pharmaceutical companies engaging with those communities in culturally-sensitive ways. The lack of an agreed lexicon and standardized definition for “decentralized clinical trial” is one such barrier.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Documentation 52

Pharma Marketing Network

JUNE 11, 2020

And when you look through who those Twitter followers are, it’s very heavily skewed towards industry, as is the website, we’ve also put some tools on our website to be able to look at who the visitors are, by company. Don Langsdorf (EHS): 141 different pharma companies from around the world. RJ Lewis (EHS): Most definitely.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing Labelling 52

PharmaVoice

JUNE 16, 2025

Either way, reforms to the 340B program, which was created by Congress in 1992 and requires pharmaceutical companies to provide outpatient drug discounts to safety net hospitals, could be on the table.

Hospitals 130

Hospitals Mail-Order Pharmacies Drug Pricing Pharmaceutical Companies 130

pharmaphorum

MARCH 30, 2021

I definitely believe that there will be a balance between the two modes, but we have now all seen that we can actually exceed expectations by being fully digital. “That’s why I have very high hopes that when the world opens up again, we will have found incredible ways of being digital – both with our employees and our stakeholders.”.

Hospitals 111

Hospitals Communication Drug Development Pharmaceutical Companies 111

pharmaphorum

APRIL 11, 2022

The answer to this question comes back to our definition of value. Dr Catherine Taylor is vice president, medical affairs therapy area strategy in EMEA (Europe, Middle East and Africa) at the Janssen Pharmaceutical Companies of Johnson & Johnson. And it all fuels the debate: are medicines a cost or an investment?

Pharmaceutical Companies 115

Pharmaceutical Companies Pharmaceutical Companies Vaccines Packaging 115

European Pharmaceutical Review

OCTOBER 17, 2022

Sanofi has signed definitive agreements with Adragos Pharmaceutical, a German contract development and manufacturing organisation (CDMO), for the sale of its pharmaceutical manufacturing site in Kawagoe, Japan. The French pharmaceutical company will also enter into a long-term supply agreement with the CDMO.

Pharmaceutical Manufacturing 104

Pharmaceutical Manufacturing Packaging Diabetes Pharmaceutical Companies 104

pharmaphorum

NOVEMBER 19, 2020

By adopting a design-led, solutions-based approach to communications, companies can help healthcare professionals (HCPs) to better meet the needs of their patients through their comms, taking a scientific approach to creating clear, rational processes built on discovery, definition, development, and delivery in every aspect of healthcare.

Communication 95

Communication Pharmaceutical Companies Pharmaceutical Companies Vaccines 95

Pharmacy Times

JUNE 24, 2025

This is progressing through a phase 3 trial and includes comparator arms with standard-of-care treatments like daratumumab, bortezomib (Velcade; Millennium/Takeda and Janssen Pharmaceutical Companies), and lenalidomide. 2 We’re still trying to figure out where these new treatments best fit.

Pharmacy Technician 48

Pharmacy Technician Diabetes Compounding Pharmacies Pharmacy Management 48

pharmaphorum

NOVEMBER 10, 2021

Nursing homes, dialysis centres, and long-term acute care hospitals all see considerable misuse and overuse of antimicrobials among patients who are, by definition, immunocompromised or infirm.”.

Nursing Homes 105

Nursing Homes Hospitals Pharmaceutical Companies Pharmaceutical Companies 105

pharmaphorum

SEPTEMBER 25, 2020

Content is playing an increasingly prominent role in the digital transformation of pharmaceutical companies as they grapple with how to provide an engaging customer experience (CX). While many pharmaceutical companies already understand the importance of CX, they do not all have the strategies they need to implement it.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies Hospitals 59